1. Home
  2. TKLF vs QTTB Comparison

TKLF vs QTTB Comparison

Compare TKLF & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TKLF
  • QTTB
  • Stock Information
  • Founded
  • TKLF 2006
  • QTTB 2015
  • Country
  • TKLF Japan
  • QTTB United States
  • Employees
  • TKLF N/A
  • QTTB N/A
  • Industry
  • TKLF Other Specialty Stores
  • QTTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • TKLF Consumer Discretionary
  • QTTB Health Care
  • Exchange
  • TKLF Nasdaq
  • QTTB Nasdaq
  • Market Cap
  • TKLF 16.0M
  • QTTB 19.0M
  • IPO Year
  • TKLF 2022
  • QTTB N/A
  • Fundamental
  • Price
  • TKLF $3.56
  • QTTB $1.55
  • Analyst Decision
  • TKLF
  • QTTB Hold
  • Analyst Count
  • TKLF 0
  • QTTB 8
  • Target Price
  • TKLF N/A
  • QTTB $24.00
  • AVG Volume (30 Days)
  • TKLF 10.6K
  • QTTB 97.2K
  • Earning Date
  • TKLF 07-15-2025
  • QTTB 08-07-2025
  • Dividend Yield
  • TKLF N/A
  • QTTB N/A
  • EPS Growth
  • TKLF N/A
  • QTTB N/A
  • EPS
  • TKLF 1.70
  • QTTB N/A
  • Revenue
  • TKLF $219,520,631.00
  • QTTB N/A
  • Revenue This Year
  • TKLF N/A
  • QTTB N/A
  • Revenue Next Year
  • TKLF N/A
  • QTTB N/A
  • P/E Ratio
  • TKLF $2.18
  • QTTB N/A
  • Revenue Growth
  • TKLF 32.02
  • QTTB N/A
  • 52 Week Low
  • TKLF $2.20
  • QTTB $1.38
  • 52 Week High
  • TKLF $8.53
  • QTTB $53.79
  • Technical
  • Relative Strength Index (RSI)
  • TKLF 51.46
  • QTTB 40.47
  • Support Level
  • TKLF $3.20
  • QTTB $1.47
  • Resistance Level
  • TKLF $3.85
  • QTTB $1.65
  • Average True Range (ATR)
  • TKLF 0.20
  • QTTB 0.12
  • MACD
  • TKLF -0.02
  • QTTB -0.02
  • Stochastic Oscillator
  • TKLF 60.93
  • QTTB 15.69

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.

About QTTB Q32 Bio Inc. Common Stock

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function. ADX-097, the lead product candidate from Q32's complement inhibitor platform, is a humanized anti-C3d monoclonal antibody fusion protein.

Share on Social Networks: